REVIEW
Accepted on 30 Sep 2025
Optimizing Early-Phase Immunotherapy Trials: The role of biomarker enrichment strategies
doi 10.3389/fimmu.2025.1664443
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Early Phase Clinical Trials for the Development of Novel Immunotherapeutic Anti-Cancer Agents
Early Phase Clinical Trials for the Development of Novel Immunotherapeutic Anti-Cancer Agents
3,434
Total downloads
14k
Total views and downloads
Articles
STUDY PROTOCOL
Published on 06 Aug 2025
Trial in progress: phase I study of non-viral gene-modified CAR-T cell therapy for malignant solid tumors expressing EPHB4 receptor (CARTiEr)
doi 10.3389/fonc.2025.1633324
- 1,459 views
CLINICAL TRIAL
Published on 23 May 2025
First-in-human evaluation of a no-alpha interleukin–2 mutein: safety and preliminary pharmacodynamic and clinical effect
doi 10.3389/fimmu.2025.1589042
- 1,845 views
CLINICAL TRIAL
Published on 21 May 2025
Updated overall survival data and predictive biomarkers of autologous NK cells plus Sintilimab as second-line treatment for advanced non-small cell lung cancer
doi 10.3389/fimmu.2025.1595382
- 2,371 views
CLINICAL TRIAL
Published on 02 Dec 2024
Perioperative tislelizumab with four cycles of neoadjuvant chemotherapy for resectable locally advanced esophageal squamous cell carcinoma: a phase 2 study
doi 10.3389/fimmu.2024.1482005
- 2,243 views
- 2 citations
CLINICAL TRIAL
Published on 13 Nov 2024
SOX combined with tislelizumab and low-dose radiation therapy for the neoadjuvant treatment of locally advanced gastric/gastroesophageal junction adenocarcinoma: study protocol for a prospective, multicenter, single-arm, phase Ib/II clinical trial
doi 10.3389/fimmu.2024.1431957
- 2,772 views
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.3 impact factor
- 6.9 citescore